TABLE-Kohjin Bio - 9-MTH group results

About this update from Kohjin Bio Co.,ltd.

Feb 13 (Reuters)- Kohjin Bio Co., Ltd. CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 3.79 3.92 4.97 (-3.4 pct) (+10.7 pct) (-4.5 pct) Operating 387 mln 675 mln 464 mln (-42.6 pct) (+82.0 pct) (-53.1 pct) Recurring 385 mln 740 mln 467 mln (-48.0 pct) (+86.2 pct) (-56.1 pct) Net 279 mln 516 mln 335 mln (-45.9 pct) (+149.6 pct) (-57.8 pct) EPS 54.71 yen 102.95 yen 65.65 yen Ann Div 24.00 yen 10.00 yen -Q2 div NIL NIL -Q4 div 24.00 yen 10.00 yen NOTE - Kohjin Bio Co., Ltd.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T

View stock analysis, news, and events for Kohjin Bio Co.,ltd.